 Engineers Gate Manager LP reduced its stake in shares of Nektar Therapeutics NASDAQ:NKTR by 63.3 during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The fund owned 14,339 shares of the biopharmaceutical companys stock after selling 24,690 shares during the quarter. Engineers Gate Manager LPs ... 